Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Health Canada expands approved uses of Rebetron

May 3, 1999

Pivotal results demonstrate equal efficacy and better tolerability of Diacol versus NuLYTELY

May 3, 1999

Anti-HBV agents in development at Australian research center

May 3, 1999

SK-951 identified as a potent 5-HT4 agonist/5-HT3 antagonist

April 30, 1999

European CPMP emits positive opinion on Zeffix for chronic HBV

April 27, 1999

U.S. study now under way using artificial liver device incorporating human cells

April 27, 1999

Thalidomide receives orphan drug status for Crohn's disease

April 21, 1999

SciClone and Sigma-Tau sign Zadaxin partnership

April 19, 1999

COX-2 inhibitors can potentially be used safely in patients with decompensated cirrhosis

April 19, 1999

Low-dose IL-2 provides benefits in treatment-refractory HCV patients

April 16, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...